Effects of Enriched Gardens in Nursing Home Residents With Dementia

May 21, 2021 updated by: RIVAGES

Effects of Enriched Gardens on Cognition and Independence of Nursing Home Residents With Dementia: a Cluster-controlled Trial

Comparing the effect of the frequentation of an enriched garden vs sensory conventional garden by nursing home residents with Alzheimer disease. The effects will be evaluated as regards to cognitive impairment (MMSE), autonomy (ADL) and prevention of falls (Unipodal stance and UpandGo Test)

Study Overview

Detailed Description

The cluster controlled trial is conducted over a six months period after recruitment of residents from 4 different nursing homes in France. The participants are distributed into 3 groups. One group does not receive incentive from carers to visit any garden, the second group receives incentives to visit regularly a conventional sensory garden and the third group receive incentives from carers to visit regularly an enriched garden. The study is conducted over a period of 6 months. All participants are giving consent to the study. They will be evaluated before and after over 4 different tests. MMSE (Mini Mental Status Examination) for cognitive impairment, ADL (Activity for day Living) for functional autonomy, TUG (Test up and Go) and Unipodal Stance for prevention of falls.

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Val De Marne
      • Ivry-sur-Seine, Val De Marne, France, 94200
        • Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix et Sorbonne Université

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

75 years to 95 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Give consent
  • Ability walking alone
  • Alzheimer's disease

Exclusion Criteria:

  • No dementia
  • Severe dementia
  • Severe behavioural disorder
  • Inability to walk alone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: GROUP ONE
The participants do not receive incentive to visit any gardens
Placebo Comparator: GROUP TWO
The participants receive incentives by carers to visit regularly a conventional sensory garden
Carers invites every the participants of group 2 and 3 visiting their respective gardens (enriched or conventional sensory garden)
Experimental: GROUP THREE
The participants receive incentives by carers to visit regularly an enriched garden
Carers invites every the participants of group 2 and 3 visiting their respective gardens (enriched or conventional sensory garden)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in global cognitive function
Time Frame: 6 MONTHS
Mini Mental Status Examination (MMSE) , 0-30, higher score is the better outcome
6 MONTHS
Change in functional independence
Time Frame: 6 MONTHS
Activities of daily living (ADL), 0-6, higher score is the better outcome
6 MONTHS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in gait ability
Time Frame: 6 MONTHS
Timed Up and Go test (sec), higher time is the worse outcome
6 MONTHS
Change in balance
Time Frame: 6 MONTHS
Unipodal Stance (sec), higher time is the better outcome
6 MONTHS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2020

Primary Completion (Actual)

October 15, 2020

Study Completion (Actual)

October 15, 2020

Study Registration Dates

First Submitted

March 3, 2021

First Submitted That Met QC Criteria

May 21, 2021

First Posted (Actual)

May 26, 2021

Study Record Updates

Last Update Posted (Actual)

May 26, 2021

Last Update Submitted That Met QC Criteria

May 21, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

IPD will only be available to study reviewers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

Clinical Trials on INCENTIVE VISITING A GARDEN : ENRICHED OR CONVENTIONAL SENSORY GARDEN

  • UMC Utrecht
    National University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaborators
    Recruiting
    Community-acquired Pneumonia, Influenza, COVID-19
    United Kingdom, United States, Canada, Australia, Netherlands, Spain, Croatia, Belgium, New Zealand, Ireland, France, Italy, Japan, Slovenia, Colombia, India, Nepal, Pakistan, Portugal, Saudi Arabia, Germany, Israel, Czechia, Estonia, F... and more
Subscribe